Domingo Lee
Endocrinology, Diabetes & Metabolism · Indianapolis, INNPI 1528081643
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 179 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations.
Across 179 payments — averaging $13.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$414
- Mannkind Corporation$260
- AstraZeneca$241
- Antares Pharma, Inc.$199
- Amgen$165
- Corcept Therapeutics$164
- plus $908 from 19 others
What the payments were for
- Food & beverage$2,345100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 45 | $414 |
| Mannkind Corporation | 19 | $260 |
| AstraZeneca(2 entities) | 15 | $241 |
| Antares Pharma, Inc. | 14 | $199 |
| Amgen | 13 | $165 |
| Corcept Therapeutics | 10 | $164 |
| Sanofi-aventis U.S. LLC | 13 | $156 |
| Shire North American Group Inc | 7 | $119 |
| Amneal Pharmaceuticals LLC | 6 | $97 |
| Radius Health, Inc. | 5 | $75 |
| Lilly USA, LLC | 5 | $68 |
| Amarin Pharma, Inc. | 4 | $66 |
| Vivus LLC | 4 | $49 |
| AbbVie | 2 | $48 |
| Boehringer Ingelheim | 3 | $36 |
| Lifescan, Inc. | 3 | $35 |
| Pfizer | 1 | $24 |
| Companion Medical, Inc. | 2 | $24 |
| Kowa Pharmaceuticals America, Inc. | 2 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| IBSA Pharma Inc. | 1 | $14 |
| Eisai Inc. | 1 | $12 |
| Merck | 1 | $11 |
How this compares
$2,351 in reported general payments places this provider in the 55th percentile of 134 endocrinology, diabetes & metabolism providers in Indiana.
See all endocrinology, diabetes & metabolism providers in Indiana →
Other endocrinology, diabetes & metabolism in Indianapolis
- Ernest AsamoahIndianapolis$959K
- Hisham AllababidiIndianapolis$195K
- Michael EconsIndianapolis$74K
- Carmella Evans-MolinaIndianapolis$55K
- Manuel Bello SeguraIndianapolis$44K
- Moazzam HabibIndianapolis$29K
- James EdmondsonIndianapolis$10K
- James ScheidlerIndianapolis$8K
- Cary MariashIndianapolis$6K
- Jayender ChintaparthiIndianapolis$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.